Related Experiment Video
Updated: Jun 7, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Senescence as a modulator of oral squamous cell carcinoma development
1Centre for Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Turner Street, London E1 2AD, England, UK. e.k.parkinson@qmul.ac.uk
Abstract:
Senescence of somatic cells in vitro can occur through the gradual erosion of the chromosomal telomeres following multiple rounds of cell division, or more acutely following cellular stresses connected with oncogene activation, tumour suppressor loss, ageing and migration. These various forms of senescence are associated with the activation of DNA damage checkpoints, the over-expression of p16(INK4A) and the secretion of cytokines, all of which are detected in pre-malignant lesions but muted upon malignant conversion. The various senescence signals are integrated by p16(INK4A) and p53 to produce the permanent cell cycle arrest associated with senescence. Both pRB/p16(INK4A) and p53 are dysfunctional in many cancers, including the most common type of oral cancer, squamous cell carcinoma (OSCC) and other evidence is accumulating in support of the idea that senescence acts as a barrier to tumour development and/or progression. However, senescence of the non-epithelial component of developing human tumours has been shown to enhance growth and invasion of the pre-malignant epithelial component and so senescence may well enhance cancer as well as suppress it depending on the context.
Insights
Cellular senescence, a state of permanent cell cycle arrest, can prevent tumor development but may also promote cancer progression in certain contexts, highlighting its complex role in oncology.
Area of Science:
- Cellular Biology
- Oncology
- Molecular Biology
Background:
- Cellular senescence is a response to various stresses, including telomere shortening and oncogene activation.
- Senescence involves DNA damage checkpoints, p16(INK4A) overexpression, and cytokine secretion, often observed in pre-malignant lesions.
- The p16(INK4A) and p53 pathways integrate senescence signals, leading to cell cycle arrest.
Purpose of the Study:
- To explore the dual role of cellular senescence as both a tumor suppressor and a potential promoter of cancer.
- To investigate the mechanisms by which senescence influences tumor development and progression.
- To understand the context-dependent functions of senescence in various cancers, including oral squamous cell carcinoma.
Main Methods:
- Analysis of cellular senescence markers (e.g., p16(INK4A), p53) in pre-malignant and malignant lesions.
- Investigation of the impact of senescence in non-epithelial tumor components on epithelial growth and invasion.
- Review of existing evidence on the interplay between senescence pathways and cancer development.
Main Results:
- Senescence acts as a barrier to tumor initiation and progression by inducing permanent cell cycle arrest.
- Dysfunction of pRB/p16(INK4A) and p53 pathways is common in cancers like oral squamous cell carcinoma (OSCC).
- Senescence in the non-epithelial tumor stroma can paradoxically enhance the growth and invasion of malignant epithelial cells.
Conclusions:
- Cellular senescence exhibits context-dependent roles in cancer, acting as both a tumor suppressor and a promoter.
- Understanding the specific mechanisms and tumor microenvironment is crucial for harnessing senescence as a therapeutic strategy.
- Further research is needed to elucidate the intricate balance between senescence-induced tumor suppression and promotion.
Related Concept Videos
Replicative Cell Senescence
Replicative Cell Senescence
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cellular Adaptation IV: Dysplasia and Metaplasia
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
